Overview of azathioprine treatment in multiple sclerosis

[1]  A V Swan,et al.  An assessment of disability rating scales used in multiple sclerosis. , 1991, Archives of neurology.

[2]  D. Goodkin,et al.  The efficacy of azathioprine in relapsing ‐ remitting multiple sclerosis , 1991, Neurology.

[3]  J. Noseworthy,et al.  Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial , 1990, Neurology.

[4]  M. R. Mickey,et al.  A placebo‐controlled, randomized, double‐masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis , 1989, Neurology.

[5]  R. Hughes,et al.  IMMUNOLOGICAL TREATMENT FOR MULTIPLE SCLEROSIS , 1989, The Lancet.

[6]  J. Kurtzke,et al.  The Disability Status Scale for multiple sclerosis , 1989, Neurology.

[7]  D. Goodkin,et al.  Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests. , 1988, Archives of physical medicine and rehabilitation.

[8]  R Peto,et al.  Why do we need systematic overviews of randomized trials? , 1987, Statistics in medicine.

[9]  L. Kinlen.  Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. , 1985, The American journal of medicine.

[10]  M. R. Mickey,et al.  An illness severity score for multiple sclerosis , 1984, Neurology.

[11]  H. Weiner,et al.  Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. , 1983, The New England journal of medicine.

[12]  A. Compston,et al.  DOUBLE-BLIND CONTROLLED TRIAL OF IMMUNOSUPPRESSION IN THE TREATMENT OF MULTIPLE SCLEROSIS: FINAL REPORT , 1982, The Lancet.

[13]  H. Hecker,et al.  Azathioprine in treatment of multiple sclerosis Final results of a 4 1 2 -Year controlled study of its effectiveness covering 115 patients , 1982, Journal of the Neurological Sciences.

[14]  J. A. Rosen.  Prolonged azathioprine treatment of non-remitting multiple sclerosis , 1979, Journal of neurology, neurosurgery, and psychiatry.

[15]  H. Deicher,et al.  [Treatment of multiple sclerosis with levamisole and azathioprine. Comparison of the effectiveness, of an 'immunostimulative' and 'immunosuppressive' treatment (author's transl)]. , 1978, Der Nervenarzt.

[16]  O. Hommes,et al.  Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone , 1975, Clinical Neurology and Neurosurgery.

[17]  L. Liversedge,et al.  Long-term treatment of multiple sclerosis with azathioprine , 1973, Journal of neurology, neurosurgery, and psychiatry.

[18]  L. Wilkins.  Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report. , 1970 .

[19]  F. Mcdowell,et al.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS , 1965, Annals of the New York Academy of Sciences.

[20]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .